Cite
MLA Citation
David Sumerauer et al.. “LGG-31. SUSTAINED OBJECTIVE RESPONSE TO DABRAFENIB THERAPY ACROSS DIFFERENT BRAIN HISTOLOGIES HARBOURING BRAF V600E ACTIVATING MUTATION.” Neuro-oncology, vol. 20, no. 2, n.d., p. i111. http://access.bl.uk/ark:/81055/vdc_100095485722.0x00000d